| text 
Vira Shield®
Product information on this website is for Non-U.S. residents only and is provided by Novartis Animal Health Inc. for general purposes only. Many veterinary products listed are available upon prescription only, and not all such products may be available in all countries. The product information is not intended to provide complete medical information. SHOULD YOUR ANIMAL HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN VETERINARIAN. WE DO NOT OFFER PERSONALIZED MEDICAL DIAGNOSIS OR ANIMAL-SPECIFIC TREATMENT ADVICE. You should always obtain complete medical information about your veterinary product prescription (including their beneficial medical uses and possible adverse effects) by discussing the appropriate use of any veterinary product directly with the prescribing veterinarian.
Veterinary professionals may obtain complete medical information from the product's information leaflet. Information on these products may vary by country. Animal owners and veterinarians should check with local medical resources and regulatory authorities for information appropriate to their country. In addition, current regulations in many countries limit (or even prohibit in some instances) the ability of Novartis Animal Health Inc. to provide information and/or to respond directly to questions regarding its prescription products. Novartis Animal Health Inc., however, will respond to inquiries from and provide information to your qualified health care professional in accordance with local regulations.
Description
Product Type
A vaccine for the prevention of a broad spectrum of respiratory and reproductive diseases of beef and dairy cattle.
Description and Composition
All Vira Shield 6 combinations are ready-to-use formulations that contain antigens of both biotypes, and the 2 most common genotypes, of bovine virus diarrhea (BVD): NCP Type 1, NCP Type 2 and CP Type 1 plus IBR, PI3 and BRSV. All combinations contain the adjuvant Xtend® SP.
Properties
All Vira Shield 6 combinations contain inactivated viruses. It is the first vaccine line to feature three-way BVD coverage.
Xtend SP adjuvant increases the animal’s immune response to the vaccine. It stimulates cell-mediated and humoral immune response, resulting in elevated, long-lasting protection. This adjuvant, in part, explains the 11-month duration of immunity for Type 2 BVD provided by Vira Shield 6 combinations.
Indications
Vira Shield is indicated for the prevention of IBR, BVD, PI3 and BRSV in beef and dairy cattle. Additional diseases are prevented by specific Vira Shield 6 combinations that contain the appropriate antigens.
Dosage and Administration
The initial vaccination involves two 5-mL doses administered four to five weeks apart. Annual revaccination is required. The vaccine is administered subcutaneously in the neck, except for combinations containing H. somnus, which must be administered intramuscularly in the neck.
Vira Shield 6 combinations may be administered to pregnant cows and calves nursing pregnant cows, regardless of vaccination history. They may be given to beef cattle at various reproduction stages, including pre-breeding, pregnancy checking, branding/turnout and pre-weaning and weaning. They are also recommended for dairy cattle at dry-off or close-up.
Special Precautions and Warnings
Consult the product label/monograph specific to your country.
Formulations and Packages
Vira Shield 6 is available in 10-dose and 50-dose bottles.
U.S. Residents
This is an international website and is intended for residents outside the US.
If you are a Consumer or Veterinarian in the USA and have questions about our products, please call:
Novartis Technical Product Services Group
1-800-637-0281